You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復宏漢霖(2696.HK):一季度營收同比大增97.2%至9.957億元 核心產品加速放量
格隆匯 04-17 08:55
格隆匯4月17日丨2023年第一季度,公司成功實現營業收入約人民幣9.957億元,相比去年同期增幅約97.2%,漢曲優、漢斯狀等核心商業化產品加速放量,引領銷售收入持續增長。公司抗腫瘤領域的核心產品漢曲優®(商業化增長態勢迅猛,實現國內銷售收入約人民幣5.386億元,較去年同期增幅約66.7%。公司首個創新產品H藥 漢斯狀®(斯魯利單抗注射液)實現國內銷售收入約人民幣2.498億元。值得一提的是,該產品於2023年3月首次實現中國境內(不包含港澳台地區)單月銷售額過億,標誌着其已邁入銷售增長新階段,產品的商業化發展獲得強勁動力。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account